Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McGill University

$367,200.00

Characterization of the newly uncovered internationally prevalent GAA triplet expansion late-onset SCA27B ataxia that is more common in Quebec: from improved phenotyping, genotyping to molecular pathological understanding

EF 2022-23

Résumé
When gait becomes ataxic in aging it has a major negative impact on quality of life and risk of falls. Decreased balance after the age of 30 caused by cerebellar disease is rare, with 1:33,000 people affected. The late-onset cerebellar ataxias (LOCA) as a group have largely resisted gene identification until our recent identification of a dominant intronic repeat expansion in the FGF14 gene causing LOCA with frequent episodic features. This novel non-coding trinucleotide expansion was uncovered in 73 cases from 43 Quebec families, explaining 61% of LOCA families, making it the most frequent form of LOCA in Quebec. The same expansion was found in 10-51% of patients with LOCA in more than 15 different populations, supporting that this expansion is likely the most common genetic cause of LOCA identified to date. Patients develop a slowly progressive cerebellar syndrome at an average age of 59 years and the disease has episodic manifestations such as double vision, nystagmus, vertigo, dysarthria, and gait ataxia in 46% of cases. Close to a third of patients have no previous family history of ataxia. Many patients eventually require a walking aid. We propose a multidisciplinary approach that relies on a Canadian and international collaboration to gain a better understanding of the clinical spectrum of the disease and establish how the expansion's dynamic leads to cerebellar dysfunction. This research program will allow a large group of Canadians to reach a genetic diagnosis for their late-onset ataxia, thus putting an end to their diagnostic odyssey. This research program will also help support therapy development. This study is significant as it demonstrates the importance of genetic research in identifying the basis behind the variability of late-onset neurodegenerative diseases that influence the loss of normal gait in ageing.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
478132
Name
Brais Bernard
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
Genetics
Projecttitle
Characterization of the newly uncovered internationally prevalent GAA triplet expansion late-onset SCA27B ataxia that is more common in Quebec: from improved phenotyping, genotyping to molecular pathological understanding
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$367,200
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Aging; Ataxia; Cerebellum; Chanelopathy; Gait; Neurodegeneration
Abstract
When gait becomes ataxic in aging it has a major negative impact on quality of life and risk of falls. Decreased balance after the age of 30 caused by cerebellar disease is rare, with 1:33,000 people affected. The late-onset cerebellar ataxias (LOCA) as a group have largely resisted gene identification until our recent identification of a dominant intronic repeat expansion in the FGF14 gene causing LOCA with frequent episodic features. This novel non-coding trinucleotide expansion was uncovered in 73 cases from 43 Quebec families, explaining 61% of LOCA families, making it the most frequent form of LOCA in Quebec. The same expansion was found in 10-51% of patients with LOCA in more than 15 different populations, supporting that this expansion is likely the most common genetic cause of LOCA identified to date. Patients develop a slowly progressive cerebellar syndrome at an average age of 59 years and the disease has episodic manifestations such as double vision, nystagmus, vertigo, dysarthria, and gait ataxia in 46% of cases. Close to a third of patients have no previous family history of ataxia. Many patients eventually require a walking aid. We propose a multidisciplinary approach that relies on a Canadian and international collaboration to gain a better understanding of the clinical spectrum of the disease and establish how the expansion's dynamic leads to cerebellar dysfunction. This research program will allow a large group of Canadians to reach a genetic diagnosis for their late-onset ataxia, thus putting an end to their diagnostic odyssey. This research program will also help support therapy development. This study is significant as it demonstrates the importance of genetic research in identifying the basis behind the variability of late-onset neurodegenerative diseases that influence the loss of normal gait in ageing.
Competitiondate
202303
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Brais, Bernard
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $367,200~ $0~